These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27730087)

  • 1. The inositols and polycystic ovary syndrome.
    Kalra B; Kalra S; Sharma JB
    Indian J Endocrinol Metab; 2016; 20(5):720-724. PubMed ID: 27730087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS.
    Wojciechowska A; Osowski A; Jóźwik M; Górecki R; Rynkiewicz A; Wojtkiewicz J
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositols in PCOS.
    Kamenov Z; Gateva A
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33260918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inositols: From Established Knowledge to Novel Approaches.
    Dinicola S; Unfer V; Facchinetti F; Soulage CO; Greene ND; Bizzarri M; Laganà AS; Chan SY; Bevilacqua A; Pkhaladze L; Benvenga S; Stringaro A; Barbaro D; Appetecchia M; Aragona C; Bezerra Espinola MS; Cantelmi T; Cavalli P; Chiu TT; Copp AJ; D'Anna R; Dewailly D; Di Lorenzo C; Diamanti-Kandarakis E; Hernández Marín I; Hod M; Kamenov Z; Kandaraki E; Monastra G; Montanino Oliva M; Nestler JE; Nordio M; Ozay AC; Papalou O; Porcaro G; Prapas N; Roseff S; Vazquez-Levin M; Vucenik I; Wdowiak A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
    Gateva A; Unfer V; Kamenov Z
    Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Chiro-inositol and PCOS: between myth and reality. The never-ending story.
    Cianci A; Vitale SG
    Int J Food Sci Nutr; 2022 Aug; 73(5):565-570. PubMed ID: 35057707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.
    Sortino MA; Salomone S; Carruba MO; Drago F
    Front Pharmacol; 2017; 8():341. PubMed ID: 28642705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of inositols treatment for PCOS before and during ART.
    Artini PG; Malacarne E; Tomatis V; Genazzani AD
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4799-4809. PubMed ID: 34337729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Monastra G; Unfer V; Harrath AH; Bizzarri M
    Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
    Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study.
    Troisi J; Cinque C; Giugliano L; Symes S; Richards S; Adair D; Cavallo P; Sarno L; Scala G; Caiazza M; Guida M
    J Ovarian Res; 2019 Mar; 12(1):25. PubMed ID: 30904021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
    Unfer V; Porcaro G
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositols in Midlife.
    Kalra S; Kalra B
    J Midlife Health; 2018; 9(1):36-38. PubMed ID: 29628727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.
    Facchinetti F; Appetecchia M; Aragona C; Bevilacqua A; Bezerra Espinola MS; Bizzarri M; D'Anna R; Dewailly D; Diamanti-Kandarakis E; Hernández Marín I; Kamenov ZA; Kandaraki E; Laganà AS; Monastra G; Montanino Oliva M; Nestler JE; Orio F; Ozay AC; Papalou O; Pkhaladze L; Porcaro G; Prapas N; Soulage CO; Stringaro A; Wdowiak A; Unfer V
    Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):255-274. PubMed ID: 32129111
    [No Abstract]   [Full Text] [Related]  

  • 17. An innovative approach to polycystic ovary syndrome.
    Bizzarri M; Logoteta P; Monastra G; Laganà AS
    J Obstet Gynaecol; 2022 May; 42(4):546-556. PubMed ID: 34169781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
    Mendoza N; Diaz-Ropero MP; Aragon M; Maldonado V; Llaneza P; Lorente J; Mendoza-Tesarik R; Maldonado-Lobon J; Olivares M; Fonolla J
    Gynecol Endocrinol; 2019 Aug; 35(8):695-700. PubMed ID: 30880505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials.
    Mendoza N; Pérez L; Simoncini T; Genazzani A
    Reprod Biomed Online; 2017 Nov; 35(5):529-535. PubMed ID: 28756130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
    J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.